GD

Gregory A. Demopulos

OM Omeros: 46 patents #1 of 108Top 1%
UL University Of Leicester: 16 patents #2 of 136Top 2%
OS Omeros Medical Systems: 13 patents #1 of 17Top 6%
RL Rayner Intraocular Lenses Limited: 2 patents #2 of 16Top 15%
University of California: 1 patents #8,022 of 18,278Top 45%
Overall (All Time): #33,547 of 4,157,543Top 1%
65
Patents All Time

Issued Patents All Time

Showing 1–25 of 65 patents

Patent #TitleCo-InventorsDate
12351648 Methods of inhibiting MASP-2 for the treatment and/or prevention of coronavirus-induced acute respiratory distress syndrome Tineka J. Quinton 2025-07-08
12167999 Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions Vincent A. Florio 2024-12-17
12133842 Stable preservative-free mydriatic and anti-inflammatory solutions for injection Hui-Rong Shen, Clark E. Tedford 2024-11-05
12005117 Methods for inhibiting fibrosis in a subject in need thereof Nigel John Brunskill, Thomas Dudler, Hans-Wilhelm Schwaeble 2024-06-11
11981749 Methods for treating conditions associated with MASP-2 dependent complement activation Thomas Dudler, Hans-Wilhelm Schwaeble 2024-05-14
11981748 Methods for inhibiting angiogenesis in a subject in need thereof Hans-Wilhelm Schwaeble, Thomas Dudler, Larry W. Tjoelker 2024-05-14
11896621 Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant Thomas Dudler, Hans-Wilhelm Schwaeble 2024-02-13
11884742 Methods for treating conditions associated with MASP-2 dependent complement activation Hans-Wilhelm Schwaeble, Clark E. Tedford, James Brian Parent, Thomas Dudler 2024-01-30
11883493 Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders W. Jason Cummings, Thomas Dudler, Larry W. Tjoelker, Christi L. Wood, Munehisa Yabuki 2024-01-30
11628217 Highly concentrated low viscosity MASP-2 inhibitory antibody formulations, kits, and methods Kenneth M. Ferguson, William Joseph Lambert, John Steven Whitaker 2023-04-18
11525011 Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome Thomas Dudler, Hans-Wilhelm Schwaeble 2022-12-13
11464785 Treatment of addiction and impulse-control disorders using PDE7 inhibitors George A. Gaitanaris, Roberto Ciccocioppo 2022-10-11
11234965 Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions Vincent A. Florio 2022-02-01
11207275 Treatment of addiction and impulse-control disorders using PDE7 inhibitors George A. Gaitanaris 2021-12-28
11027015 Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders W. Jason Cummings, Thomas Dudler, Larry W. Tjoelker, Christi L. Wood, Munehisa Yabuki 2021-06-08
11013772 Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant Thomas Dudler, Hans-Wilhelm Schwaeble 2021-05-25
10870708 Methods for inhibiting angiogenesis in a subject in need thereof Hans-Wilhelm Schwaeble, Thomas Dudler, Larry W. Tjoelker 2020-12-22
10745274 Nucleic acids encoding antibodies specifically binding to MASP-3 W. Jason Cummings, Thomas Dudler, Larry W. Tjoelker, Christi L. Wood, Munehisa Yabuki 2020-08-18
10736960 Methods for inhibiting fibrosis in a subject in need thereof Nigel John Brunskill, Tom Dudler, Hans-Wilhelm Schwaeble 2020-08-11
10639369 Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders W. Jason Cummings, Thomas Dudler, Larry W. Tjoelker, Christi L. Wood, Munehisa Yabuki 2020-05-05
10626184 Monoclonal antibodies, compositions and methods for detecting mucin-like protein (MLP) as a biomarker for ovarian and pancreatic cancer Hans-Wilhelm Schwaeble 2020-04-21
10202465 Methods for treating conditions associated with MASP-2 dependent complement activation Thomas Dudler, Hans-Wilhelm Schwaeble 2019-02-12
10059776 Methods for treating conditions associated with MASP-2 dependent complement activation Thomas Dudler, Hans-Wilhelm Schwaeble 2018-08-28
9855256 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures Jeffrey M. Herz, Wayne R. Gombotz, Hui-Rong Shen 2018-01-02
9855246 Stable preservative-free mydriatic and anti-inflammatory solutions for injection Hui-Rong Shen, Clark E. Tedford 2018-01-02